Skip to main content Skip to main navigation menu Skip to site footer

TNF-α serum level between SARS-CoV-2 infected pregnant women with normal pregnant women in Dr. Soetomo General Hospital Surabaya

  • Margaretha Claudhya Febryanna ,
  • Manggala Pasca Wardhana ,
  • Muhammad Ilham Aldika Akbar ,
  • Arif Rahman Nurdianto ,

Abstract

Background: Pregnant women infected with SARS-CoV-2 experienced increased pro-inflammatory cytokines, including TNF-α, resulting in a cytokine storm condition. This study aimed to compare TNF-α levels between pregnant women infected and not infected with COVID-19 in the third trimester.

Method: This observational research was conducted with cross sectional design. Our study included pregnant women who came to the delivery room/inpatient at Dr. Soetomo General Hospital Surabaya before or during labor between May and June 2021. The inclusion criteria were third trimester gestational age or >28 weeks with SARS-RT-PCR nasopharyngeal swab result. The exclusion criteria were all significant pregnancy complications. The pregnant woman coming to the delivery room will be screened for COVID-19, and blood samples will be examined using the flow cytometry method for the cytokine Th1: TNF-α.

Result: There were no significant differences in TNF-α levels in pregnant women who were infected and not infected with COVID-19 (median 3.42 (7.24) pg/ml vs. 2.70 (3.06) pg/ml. p=0.138). There was also no significant difference in TNF-α levels in pregnant women with symptomatic vs. asymptomatic COVID-19 infection (3.21(3.97) vs. 2.41(2.71) pg/ml; p=0.314).

Conclusion: This study revealed no significant difference in TNF-α serum level between SARS-CoV-2 infected pregnant women with normal pregnant women.

References

  1. Narang K, Enninga EAL, Gunaratne MDSK, Ibirogba ER, Trad ATA, Elrefaei A, et al. SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review. Mayo Clin Proc. 2020/05/30. 2020;95(8):1750–65. Available from: https://pubmed.ncbi.nlm.nih.gov/32753148
  2. Kurniawati D, Prasetyo B, Pandu H, Nurdianto AR. Clinical presentation of maternal death with COVID-19 in rural tertiary care center: A retrospective-descriptive Study. Bali Med J. 2022;11(1):87–90. Available from: https://doi.org/10.15562/bmj.v11i1.3158
  3. Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010/03/29. 2010;63(6):425–33. Available from: https://pubmed.ncbi.nlm.nih.gov/20367629
  4. Yockey LJ, Iwasaki A. Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development. Immunity. 2018;49(3):397–412. Available from: https://pubmed.ncbi.nlm.nih.gov/30231982
  5. Robinson PC, Liew DFL, Liew JW, Monaco C, Richards D, Shivakumar S, et al. The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19. Med (New York, NY). 2020/12/03. 2020;1(1):90–102. Available from: https://pubmed.ncbi.nlm.nih.gov/33294881
  6. Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020/06/02. 2020;54:62–75. Available from: https://pubmed.ncbi.nlm.nih.gov/32513566
  7. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020/03/03. 2020;46(5):846–8. Available from: https://pubmed.ncbi.nlm.nih.gov/32125452
  8. Wardhana MP, Aditiawarman MNC, Aditya R, Gumilar KE, Wicaksono B, Akbar MIA, et al. Lesson from Indonesia: Covid-19 testing strategy in obstetric emergency cases at low-resource health care setting. Pakistan J Med Heal Sci. 2021;15(2):508–13.
  9. Wardhana MP, Dachlan EG, Harvanda PA, Gumilar KE, Wicaksono B, Akbar MIA, et al. Maternal and perinatal outcome of covid-19 in obstetric cases: 9 months experience from east java tertiary referral hospital. New Armen Med J. 2021;15(3):39–46.
  10. Chi Y, Ge Y, Wu B, Zhang W, Wu T, Wen T, et al. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China. J Infect Dis. 2020;222(5):746–54. Available from: https://pubmed.ncbi.nlm.nih.gov/32563194
  11. Lu Q, Zhu Z, Tan C, Zhou H, Hu Y, Shen G, et al. Changes of serum IL‐10, IL‐1β, IL‐6, MCP‐1, TNF‐α, IP‐10 and IL‐4 in COVID‐19 patients. Int J Clin Pract. 2021;75(9):e14462.
  12. Merza MY, Hwaiz RA, Hamad BK, Mohammad KA, Hama HA, Karim AY. Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq. PLoS One. 2021;16(4):e0250330. Available from: https://doi.org/10.1371/journal.pone.0250330
  13. Salomon BL, Leclerc M, Tosello J, Ronin E, Piaggio E, Cohen JL. Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology. Front Immunol. 2018;9:444. Available from: https://pubmed.ncbi.nlm.nih.gov/29593717
  14. Chan HLY, Tsui SKW, Sung JJY. Coronavirus in severe acute respiratory syndrome (SARS). Trends Mol Med. 2003;9(8):323–5. Available from: https://pubmed.ncbi.nlm.nih.gov/12928031
  15. Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9(1):1123–30.
  16. Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes. Cell. 2020/11/19. 2021;184(1):149-168.e17. Available from: https://pubmed.ncbi.nlm.nih.gov/33278357
  17. Chen J, Lau YF, Lamirande EW, Paddock CD, Bartlett JH, Zaki SR, et al. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J Virol. 2009/11/11. 2010;84(3):1289–301. Available from: https://pubmed.ncbi.nlm.nih.gov/19906920

How to Cite

Febryanna, M. C. ., Wardhana, M. P., Akbar, M. I. A. ., & Nurdianto, A. R. (2022). TNF-α serum level between SARS-CoV-2 infected pregnant women with normal pregnant women in Dr. Soetomo General Hospital Surabaya. Bali Medical Journal, 11(3), 1059–1062. https://doi.org/10.15562/bmj.v11i3.3479

HTML
0

Total
0

Share

Search Panel

Margaretha Claudhya Febryanna
Google Scholar
Pubmed
BMJ Journal


Manggala Pasca Wardhana
Google Scholar
Pubmed
BMJ Journal


Muhammad Ilham Aldika Akbar
Google Scholar
Pubmed
BMJ Journal


Arif Rahman Nurdianto
Google Scholar
Pubmed
BMJ Journal